<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02024256</url>
  </required_header>
  <id_info>
    <org_study_id>MG33</org_study_id>
    <nct_id>NCT02024256</nct_id>
  </id_info>
  <brief_title>Cold Magnesium Sulfate Solution for Perineal Swelling Following Vaginal Delivery</brief_title>
  <acronym>MgSo4</acronym>
  <official_title>Comparison Between Treatment With Gauze Soaked With Cold Magnesium Sulfate Solution Against Gauze Soaked With Cold Water for Treatment of Perineal Swelling Following Vaginal Delivery - A Double Blind Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the impact of treatment with cooled magnesium sulfate&#xD;
      and cold water-soaked pads on perineal pain and swelling following vaginal delivery.&#xD;
&#xD;
      Assessment of appropriateness for each patient to take part in the study will be performed&#xD;
      approximately 2 hours following delivery. Those patients who consent to participate in the&#xD;
      trial will be allocated to treatment groups in a double-blinded, randomized manner. Women in&#xD;
      the study group will receive treatment with pads soaked in a cold aqueous solution of&#xD;
      magnesium sulfate at 33% (w/v) concentration, while those in the control group will receive&#xD;
      treatment with pads soaked in cold water.&#xD;
&#xD;
      Nurses will initiate treatment according to the group to which the patient was randomized.&#xD;
      Said pads will be given the patients routinely 5 times a day at regular times.&#xD;
&#xD;
      A physician will assess the perineal swelling according to visual (photographed) scale in&#xD;
      which severe, moderate, light and no swelling will be defined. Measurement of swelling in&#xD;
      centimeters (maximal length and breadth); photography, by a medical photographer or the&#xD;
      examining doctor, of the perineal area with a centimeter ruler, before, during and after&#xD;
      treatment (photography is dependent on patient approval and is not a precondition to&#xD;
      participation in the trial.); and additional examination, on the above basis, will be&#xD;
      performed regarding hemorrhoids in the event that a patient has complained of such.&#xD;
&#xD;
      A nurse will assess the perineal pain and swelling on a scale ranging from 0 to 10 prior to&#xD;
      the patient being given the pad and an hour following treatment. An additional assessment by&#xD;
      the same method will be performed regarding hemorrhoid pain. Any analgesia administered will&#xD;
      also be recorded.&#xD;
&#xD;
      Likewise, for follow-up purposes a blood test for serum magnesium concentration will be taken&#xD;
      before and after treatment.&#xD;
&#xD;
      Period of follow-up will be 48-72 hours from childbirth.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in the level of perineal pain</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in perineal swelling</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in hemorrhoids pain and swelling</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">206</enrollment>
  <condition>Vaginal Delivery</condition>
  <condition>Perineal Swelling</condition>
  <condition>Perineal Pain</condition>
  <arm_group>
    <arm_group_label>Magnesium sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pads soaked in cold magnesium sulfate solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Pads soaked with cold water</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cold pads soaked in Magnesium sulfate solution</intervention_name>
    <arm_group_label>Magnesium sulfate</arm_group_label>
    <other_name>Epson salt, MgSo4</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cold pads soaked in water</intervention_name>
    <arm_group_label>Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  parturients following normal vaginal birth or vacuum-assisted vaginal delivery&#xD;
&#xD;
          -  reporting of perineal pain equal to or greater than 3 on a 0-10 scale&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  parturients following cesarean section&#xD;
&#xD;
          -  lack of consent to take part in the study&#xD;
&#xD;
          -  parturients interested in early discharge (within 48 hours of childbirth)&#xD;
&#xD;
          -  girls under 18 years of age&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zohar Nahum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HaEmek medical center affiliated to Rappaport faculty of medicine, Technion, Haifa, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zohar Nahum, MD</last_name>
    <phone>97246494158</phone>
    <email>nachum_zo@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irit Friedman, MA</last_name>
    <phone>972546202261</phone>
    <email>iritdavid@gmail.com, irit_da@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HeEmek medical center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zohar Nahum, md</last_name>
      <phone>97241584649</phone>
      <email>nachum_zo@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Irit Friedman</last_name>
      <phone>972546202261</phone>
      <email>iritdavid@gmail.com, irit_da@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Zohar Nahum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HaEmek medical center</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nahum Zohar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>December 25, 2013</study_first_submitted>
  <study_first_submitted_qc>December 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2013</study_first_posted>
  <last_update_submitted>September 29, 2016</last_update_submitted>
  <last_update_submitted_qc>September 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vaginal delivery</keyword>
  <keyword>Perineal swelling</keyword>
  <keyword>Perineal pain</keyword>
  <keyword>MgSo4</keyword>
  <keyword>Magnesium sulfate</keyword>
  <keyword>Cold water</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

